Synopsys, Inc.
393.22USD
+1.1900 (+0.30%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $4.13▲ | $4 | 12 | 0 |
| Next quarter | $4.34▲ | $4.28 | 8 | 4 |
| Current year | $15.14▲ | $14.79 | 17 | 0 |
| Next year | $17.51▲ | $17.23 | 14 | 1 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-07-31 | $3.67 | $3.91 | +0.24 (+6.4%) |
| 2026-04-30 | $3.16 | $3.35 | +0.19 (+6.0%) |
| 2026-01-31 | $3.56 | $3.77 | +0.21 (+6.0%) |
| 2025-10-31 | $2.78 | $2.9 | +0.12 (+4.2%) |
278 ratings from 31 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Morgan Stanley | Upgraded from Equal-Weight | Overweight | $500 | Sep 8, 2026 |
| Mizuho | Maintained | Outperform | $600 $550 | Aug 27, 2026 |
| Baird | Upgraded from Neutral | Outperform | $558 $560 | Aug 27, 2026 |
| Rosenblatt | Maintained | Buy | $575 | Aug 27, 2026 |
| Benchmark | Reiterated | Buy | $570 | Aug 27, 2026 |
| Needham | Reiterated | Buy | $580 | Aug 27, 2026 |
| Rosenblatt | Maintained | Buy | $575 | Aug 25, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $525 $500 | Aug 19, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $535 $450 | Aug 11, 2026 |
| Benchmark | Initiated | Buy | $570 | Jul 16, 2026 |
| Piper Sandler | Upgraded from Neutral | Overweight | $450 $550 | Jun 23, 2026 |
| Citigroup | Maintained | Buy | $600 $610 | May 28, 2026 |
| BNP Paribas | Maintained | Underperform | $425 $450 | May 28, 2026 |
| Stifel | Maintained | Buy | $550 $600 | May 28, 2026 |
| Rosenblatt | Maintained | Buy | $575 | May 28, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $505 $535 | May 28, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $480 $525 | May 28, 2026 |
| B of A Securities | Maintained | Buy | $515 $600 | May 28, 2026 |
| Needham | Reiterated | Buy | $580 | May 28, 2026 |
| Piper Sandler | Maintained | Neutral | $430 $450 | May 28, 2026 |
| Rosenblatt | Maintained | Buy | $530 $575 | May 26, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $450 $505 | May 14, 2026 |
| Citigroup | Maintained | Buy | $580 $600 | May 13, 2026 |
| Morgan Stanley | Downgraded from Overweight | Equal-Weight | $550 $480 | Feb 27, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $500 $450 | Feb 26, 2026 |
104 filings from 23 insiders · 25 buy / 4 sell over 6m
Officers and directors of SNPS, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| LEE JANETOfficer, GC & Corporate Secretary | ExerciseRestricted Stock Units | 699 | — | — | Sep 1, 2026 |
| LEE JANETOfficer, GC & Corporate Secretary | Tax | 304 | $414.82 | $126k | Sep 1, 2026 |
| LEE JANETOfficer, GC & Corporate Secretary | Exercise | 699 | — | — | Sep 1, 2026 |
| DE GEUS AARTDirector; Officer, EXECUTIVE CHAIR | ExerciseNon-Qualified Stock Option (right to buy) | 24.6k | — | — | Sep 1, 2026 |
| DE GEUS AARTDirector; Officer, EXECUTIVE CHAIR | Sell | 24.6k | $419.44 | $10.34M | Sep 1, 2026 |
| DE GEUS AARTDirector; Officer, EXECUTIVE CHAIR | Exercise | 24.6k | $135.88 | $3.35M | Sep 1, 2026 |
| Ghazi SassineDirector; Officer, PRESIDENT AND CEO | Other | 27 | $360.96 | $10k | Aug 31, 2026 |
| Kankanwadi SudhindraOfficer, Deputy CFO & CAO | Other | 27 | $360.96 | $10k | Aug 31, 2026 |
| Ellow MichaelOfficer, Chief Revenue Officer | Other | 27 | $360.96 | $10k | Aug 31, 2026 |
| DE GEUS AARTDirector; Officer, EXECUTIVE CHAIR | ExerciseNon-Qualified Stock Option (right to buy) | 25.0k | — | — | Aug 31, 2026 |
| DE GEUS AARTDirector; Officer, EXECUTIVE CHAIR | Other | 22 | $360.96 | $8k | Aug 31, 2026 |
| DE GEUS AARTDirector; Officer, EXECUTIVE CHAIR | Sell | 25.0k | $441.76 | $11.04M | Aug 31, 2026 |
| DE GEUS AARTDirector; Officer, EXECUTIVE CHAIR | Exercise | 25.0k | $135.88 | $3.40M | Aug 31, 2026 |
| DE GEUS AARTDirector; Officer, EXECUTIVE CHAIR | ExerciseNon-Qualified Stock Option (right to buy) | 25.0k | — | — | Aug 28, 2026 |
| DE GEUS AARTDirector; Officer, EXECUTIVE CHAIR | Sell | 25.0k | $445.55 | $11.14M | Aug 28, 2026 |
| DE GEUS AARTDirector; Officer, EXECUTIVE CHAIR | Exercise | 25.0k | $135.88 | $3.40M | Aug 28, 2026 |
| LEE JANETGeneral Counsel | Other | 729 | — | — | Aug 14, 2026 |
| GHAZI SASSINE EChief Executive Officer | Sell | 14.6k | $458.96 | $6.70M | Jun 15, 2026 |
| GLASER SHELAGH MChief Financial Officer | Other | 1.3k | — | — | Jun 15, 2026 |
| GHAZI SASSINE EChief Executive Officer | Exercise | 17.9k | $135.88 | $1.98M | Jun 15, 2026 |
No analyst notes on SNPS yet.
Analyst Ratings
26 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 4 | 16 | 4 | 0 | 1 | Buy2.12 |
| 1 mo ago | 3 | 16 | 5 | 0 | 1 | Buy2.20 |
| 2 mo ago | 4 | 14 | 5 | 0 | 1 | Buy2.17 |
| 3 mo ago | 3 | 13 | 6 | 0 | 1 | Buy2.26 |